Bone morphogenetic protein 4 inhibits insulin secretion from rodent beta cells through regulation of calbindin1

Gitte L Christensen1, Maria L B Jacobsen, Anna Wendt

  • 1Department of Biomedical Sciences, University of Copenhagen, Nørre Alle 20, 2100, Copenhagen, Denmark.

Diabetologia
|April 2, 2015
PubMed
Abstract

Insights

Bone morphogenetic protein 4 (BMP4) inhibits glucose-stimulated insulin secretion (GSIS) in pancreatic islets by increasing calbindin1. This mechanism, dependent on calbindin1, offers potential therapeutic targets for type 2 diabetes.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Diabetes Research

Background:

  • Type 2 diabetes is characterized by progressive loss of pancreatic beta cell function.
  • Bone morphogenetic protein 4 (BMP4) is elevated in diabetes and inhibits glucose-stimulated insulin secretion (GSIS).
  • Understanding the molecular mechanisms of BMP4-induced inhibition is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the molecular mechanism by which BMP4 inhibits GSIS.
  • To identify key molecular players involved in BMP4-mediated suppression of insulin secretion.

Main Methods:

  • Single-cell electrophysiology and live-cell Ca(2+) imaging to assess GSIS.
  • Microarray profiling, quantitative PCR, and Western blotting to analyze gene expression changes.
  • Studies using calbindin1 (Calb1) knockout mice and overexpression systems.

Main Results:

  • BMP4 significantly reduced GSIS in rodent pancreatic islets.
  • BMP4-induced inhibition of GSIS was linked to decreased Ca(2+) influx and exocytosis.
  • BMP4 upregulated the expression of the Ca(2+)-binding protein calbindin1.
  • Calbindin1 overexpression mimicked BMP4's inhibitory effect on GSIS.
  • The inhibitory effect of BMP4 on GSIS was abolished in Calb1 knockout islets.

Conclusions:

  • BMP4 inhibits GSIS in a calbindin1-dependent manner.
  • Calbindin1 mediates BMP4's effect by buffering intracellular Ca(2+), reducing channel activity, and diminishing insulin exocytosis.
  • Both BMP4 and calbindin1 represent potential therapeutic targets for treating beta cell dysfunction in diabetes.

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.6K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
17.4K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
3.2K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
9.0K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
6.4K